Potential Anti-SARS-CoV-2 Therapeutics That Target the Post-Entry Stages of the Viral Life Cycle: A Comprehensive Review

Viruses
Rami A Al-Horani, Srabani Kar

Abstract

The coronavirus disease-2019 (COVID-19) pandemic continues to challenge health care systems around the world. Scientists and pharmaceutical companies have promptly responded by advancing potential therapeutics into clinical trials at an exponential rate. Initial encouraging results have been realized using remdesivir and dexamethasone. Yet, the research continues so as to identify better clinically relevant therapeutics that act either as prophylactics to prevent the infection or as treatments to limit the severity of COVID-19 and substantially decrease the mortality rate. Previously, we reviewed the potential therapeutics in clinical trials that block the early stage of the viral life cycle. In this review, we summarize potential anti-COVID-19 therapeutics that block/inhibit the post-entry stages of the viral life cycle. The review presents not only the chemical structures and mechanisms of the potential therapeutics under clinical investigation, i.e., listed in clinicaltrials.gov, but it also describes the relevant results of clinical trials. Their anti-inflammatory/immune-modulatory effects are also described. The reviewed therapeutics include small molecules, polypeptides, and monoclonal antibodies. At the molecular level, ...Continue Reading

References

Jan 1, 1979·The Journal of International Medical Research·T C Medici, P Radielovic
Jun 1, 1992·Seminars in Arthritis and Rheumatism·G RussellH Skjodt
Jan 1, 1988·International Journal of Immunopharmacology·P O OgunbiyiP Eyre
Jan 1, 1985·Journal of Medical Virology·T N KaulP L Ogra
Oct 1, 1982·Antimicrobial Agents and Chemotherapy·H IshitsukaY Suhara
Feb 1, 1995·Critical Care Medicine·J C PreiserJ L Vincent
Dec 1, 1993·The Annals of Pharmacotherapy·L G Haile, J F Flaherty
Jul 1, 1995·The Annals of Pharmacotherapy·R BehbahaniJ D Baxter
Dec 22, 1999·Clinical Immunology : the Official Journal of the Clinical Immunology Society·R I FoxB J Kirschbaum
Apr 12, 2000·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·R BreitkreutzW Dröge
Oct 29, 2000·Annals of the Rheumatic Diseases·F C Breedveld, J M Dayer
Oct 25, 2001·Antiviral Research·B W van der StrateD K Meijer
Apr 18, 2002·Antimicrobial Agents and Chemotherapy·Aaron L Baggish, David R Hill
May 14, 2003·Transplantation Proceedings·S N Sehgal
May 14, 2003·Transplantation Proceedings·R A Kirken, Y L Wang
Dec 19, 2003·The New England Journal of Medicine·Joseph S M PeirisKlaus Stöhr
Mar 6, 2004·International Journal of Immunopathology and Pharmacology·P Ghezzi, D Ungheri
Mar 26, 2004·Transplantation Proceedings·M H KapturczakB Kaplan
Apr 20, 2004·Biometals : an International Journal on the Role of Metal Ions in Biology, Biochemistry, and Medicine·Sharon MoalemMaire E Percy
May 18, 2004·Biochemical and Biophysical Research Communications·Norio YamamotoNaoki Yamamoto
Jun 1, 2004·Antiviral Research·Robert A FloydDirk P Dittmer
Jun 11, 2004·Clinical Therapeutics·Edmund K LiBrian Tomlinson
Jun 18, 2004·Emerging Infectious Diseases·Emily L C TanLawrence W Stanton
Jul 24, 2004·The Journal of Infectious Diseases·Igor TheurlGuenter Weiss
Aug 4, 2004·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·F ChenK Y Yuen
Aug 28, 2004·Journal of Virology·John W A RossenAlexandra W C Einerhand
Aug 31, 2004·Journal of Natural Products·David J Newman, Gordon M Cragg
Nov 17, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Luni ChenChen G Wang
Jan 15, 2005·Journal of Virology·Sara AkerströmAli Mirazimi

❮ Previous
Next ❯

Citations

May 8, 2021·Methods : a Companion to Methods in Enzymology·Ankur GuptaShailendra K Saxena
Jun 3, 2021·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Denise Bellotti, Maurizio Remelli

❮ Previous
Next ❯

Clinical Trials Mentioned

NCT04410354
NCT04409262
NCT04401579
NCT04292730
NCT03891420
NCT04356677
NCT04392427
NCT04276688
NCT04347915
NCT04334928

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.